Latest From Healionics Corp.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Companies offering broadly applicable biomaterials platforms often have an identify problem and with that, a funding problem. Seattle-based Healionics Corp. is solving that problem by creating clinically focused spin-outs that just happen to be in Europe where they can capture non-dilutive funding from regional governments. The company’s first spin-out, iSTAR Medical SA, is working on ophthalmic devices, specifically a suprachoroidal drainage shunt for glaucoma. In September, iSTAR was awarded a €3.6 million ($4.7 million) grant from Belgium’s Région Wallonne government.
- Therapeutic Areas
- Renal System
- North America
- Parent & Subsidiaries
- Healionics Corp.
- Senior Management
- Mike Connolly, CEO
- Contact Info
Phone: (425) 818-1987
14787 NE 95th St.
Redmond, WA 98052
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.